NCT05227534View on ClinicalTrials.gov

Multi-canceR Early-detection Test in Asymptomatic Individuals (PREVENT)

NARecruitingINTERVENTIONAL
Enrollment

12,500

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

March 1, 2024

Study Completion Date

December 31, 2028

Conditions
CancerEarly Detection of CancerCirculating Cell-free DNA
Interventions
DEVICE

OverC multi-cancer detection blood test

Blood collection for the OverC multi-cancer detection blood test and standard-of-care screening with return of results

Trial Locations (1)

610044

RECRUITING

West China Hospital, Sichuan University, Chengdu

All Listed Sponsors
collaborator

West China Hospital

OTHER

lead

Guangzhou Burning Rock Dx Co., Ltd.

INDUSTRY